A handful of prescription drug companies control the majority of patents on new drugs and charge prices far in excess of the cost of producing the medications. The newest cancer fighting drugs are priced beyond the reach of many patients who need them.
Our research has found that most prescription drugs are developed in large part with taxpayer funds. Uninsured and insured patients, business owners, and government programs all benefit from prescription drug bulk purchasing in the form of better discounts and rebates. The only ones who don't benefit are the drug companies currently charging us outrageous prices for their products.
We need a U.S. bulk-purchasing program now, and we are working continually to make sure that we get one.